Protein Summary
May be involved in drug clearance in the placenta.
- ENST00000235532
- ENSP00000235532
- ENSG00000116885
- ENST00000354267
- ENSP00000346216
- ENST00000356637
- ENSP00000349052
- C1orf102
- NOR1
- NOR1
- C1orf102
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
histone modification site profile | 0.86 | ||
cell type or tissue | 0.73 | ||
trait | 0.61 | ||
tissue sample | 0.6 | ||
tissue | 0.57 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 28.29 (req: < 5)
Gene RIFs: 9 (req: <= 3)
Antibodies: 62 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 28.29 (req: >= 5)
Gene RIFs: 9 (req: > 3)
Antibodies: 62 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Term: 0
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0